About
CUTANEON – Skin & Hair Innovations GmbH is a privately owned, independent R&D company dedicated to the development of ground-breaking cosmeceuticals, nutraceuticals, and dermatological drugs, founded by Professor Ralf Paus. Based on its expanding IP and data portfolio, CUTANEON seeks industry collaborators and investors for defined R&D projects geared at developing and commercializing disruptive skin & hair products, with an initial focus on actives that inhibit or reverse skin aging or control hair growth and pigmentation.
CREDO & VISION
Innovation in the skin & hair product space is both our passion and expertise. Rather than subscribing to a marketing-driven product development philosophy, we are convinced that only a rigorous, top-of-the-line translational science approach to skin & hair research can generate transformative skin & hair products.
In our commitment to scientifically robust preclinical R&D, we insist on using the very best, clinically most relevant human skin and hair research models and assays currently available. We firmly believe in and practice interdisciplinary and international team science that unites basic skin research with clinical dermatology expertise already at the stage of preclinical research. Moreover, we are committed to generating environmentally responsible and sustainable skin & hair products that promise to deliver validated long-term benefits to consumers and patients.
Mission
We aim to revolutionize skin & hair product development by identifying and targeting ancient, yet previously under-appreciated signalling systems in human skin and hair: chemosensory “smell” and “taste” receptors (i.e. olfactory, taste, and TRP ion channels). The latter have been utilized for millions of years during evolution and are still very active in human skin, but as of yet await systematic targeting. It is one of CUTANEON’s core missions to generate patent-protected proofs-of-principle for the creation of early-stage innovative product platforms that stimulate or inhibit carefully selected chemosensory receptors.
Based on the pioneering research of CUTANEON’s founder, we focus on molecular targets, whose full potential have previously been missed by competitors (see product development portfolio). CUTANEON’s team and its key advisors reflect our mission: to combine the highest standards in innovative skin & hair research with profound experience in translating this into the development of highly competitive products and product pipelines.
Product development focus
Building on our world-leading translational research experience in these areas, we initially focus on the development of cosmeceuticals and nutraceuticals as well as on drug repurposing for these skin product frontiers, for which the market has long been awaiting landmark progress:
Hair growth control
(including the inhibition of unwanted hair growth and the management of inflammatory hair diseases such as alopecia areata and frontal fibrosing alopecia)
Skin pigmentation
(including UV-free tanning and tuning-down skin pigmentation)
Repigmentation of gray hair
Prevention of chemotherapy-induced hair loss
Skin and hair rejuvenation and anti-aging strategies
(incl. eyelid and facial skin)
Mitochondrial medicine in dermatology